<DOC>
	<DOCNO>NCT00558831</DOCNO>
	<brief_summary>The purpose study compare efficacy benzoyl peroxide 2.5 % cream formulation plus moisturize lotion versus benzoyl peroxide 2.5 % cream alone treatment acne vulgaris .</brief_summary>
	<brief_title>Study Benzoyl Peroxide Cream Mild Moderate Acne Vulgaris</brief_title>
	<detailed_description>The purpose study compare safety efficacy benzoyl peroxide 2.5 % cream formulation plus moisturize lotion versus benzoyl peroxide 2.5 % cream alone mild moderate acne vulgaris .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Healthy male female subject 18 35 year age . 2 . Subjects good health free facial skin disorder may interfere acne study assessment . 3 . Subjects willingness ability understand provide inform assent/consent participate study able communicate investigator . Subjects willing able follow study direction commit followup visit duration study . In addition , subject must willing accept restriction study . 4 . A minimum 2 30 inflammatory lesion ( papule pustule ) , relatively symmetrical appearance side face minimum 2 100 noninflammatory lesion ( open comedo close comedo ) relatively symmetrical appearance side face . 5 . Ongoing oral medication ( specifically acne ) acceptable provided subject stable regimen throughout study provide medication determine likely interfere study assessment . 6 . Subjects use medicate cosmetic and/or soap ( include soap contain antibacterial agent benzoyl peroxide , keratolytic agent salicylic acid , skin fresheners/astringents aftershave lotion ) duration study . 7 . Subjects agree use acne treatment ( include prescription nonprescription medication ) test site duration study . 8 . Subjects agree change facial cosmetic product study . 9 . Subjects agree use sunscreen/sunblock agent label noncomedogenic . 1 . Subjects parent subject unable understand protocol give inform consent/assent . 2 . Subjects mental illness . 3 . Subjects inflammatory acne . 4 . Subjects acne cyst nodule . 5 . Subjects acne conglobata , acne fulminans , secondary acne ( e.g . Chloracne , druginduced acne ) , acne require systemic treatment . 6 . Subjects excessive facial hair may interfere study assessment . 7 . Subjects facial skin disorder may interfere study assessment . 8 . Subjects history skin cancer actinic keratosis . 9 . Subjects use tan device within one week prior baseline study visit . 10 . Subjects apply topical product ( e.g . emollient , sunscreen ) cosmetic face least one hour prior study assessment . 11 . Use hormonal oral contraceptive acne control le 6 month prior study baseline . 12 . Subjects know allergy , history , sensitive salicylic acid , benzoyl peroxide test article component . 13 . Subjects use topical systemic medication within 14 day study entry , could interfere study assessment . This include limited following : antiinflammatory drug ( e.g . topical systemic corticosteroid systemic antihistamine ) , antiacne drug , topical oral retinoids , topical antibacterial agent face , immunosuppressive drug . Ongoing oral medication expect interfere study assessment allow subject stable regimen . 14 . Subjects currently enrol another clinical investigation enrol acne trial within period 30 day prior enrollment study . 15 . Subjects pregnant nursing . 16 . Subjects require electrolysis , wax , depilatory face conduct study . 17 . Subjects view investigator able complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Acne</keyword>
</DOC>